Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

References

• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotroph Lateral Scler. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310–22.
   PubMed Web of Science ®Google Scholar
• Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population based study. J Neurol Sci. 2008;268:28–32.
   PubMed Web of Science ®Google Scholar
• Mateen FJ, Carone M, Sorenson EJ. Patients who survive five years or more with ALS in Olmsted County, 1925–2004. J Neurol Neurosurg Psychiatry. 2010;81:1144–6.
   PubMed Web of Science ®Google Scholar
• Fujimura-Kiyono C, Kimura F, Ishida S, Nakajima H, Hosokawa T, Sugino M, et al. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1244–9.
   PubMed Web of Science ®Google Scholar
• Goh KJ, Tian S, Shahrizaila N, Ng CW, Tan CT. Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population. Amyotroph Lateral Scler. 2011;12:124–9.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Messina P, Logroscino G, Beghi E; SLALOM Group. Long-term survival in amyotrophic lateral sclerosis: a population based study. Ann Neurol. 2014;75:287–97.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat PF, Bruneteau G, et al. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience. Neurodegenerative Dis. 2013;12:81–90.
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernán MA. Association of smoking with amyotrophic lateral sclerosis risk and survival in males and females: a prospective study. BMC Neurol. 2010;10:6.
   PubMed Web of Science ®Google Scholar
• Shimuzi T, Nagaoka U, Nakayama Y, Kawata A, Kugimoto C, Kuroiwa Y, et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicentre study in Japan. Amyotroph Lateral Scler. 2012;13:363–6.
   PubMed Web of Science ®Google Scholar
• Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661–70.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Moglia C, Mazzini L, Mora G; PARALS Study Group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–70.
   PubMed Web of Science ®Google Scholar
• Berlowitz DJ, Howard ME, Fiore JF Jr, Vander Hoorn S, O’Donoghue FJ, Westlake J, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neuron disease in a clinical cohort. J Neurol Neurosurg Psychiatry 2015; doi: 10.1136/jnnp-2014-310055. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Talman P, Forbes A, Mathers S. Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database. Amyotroph Lateral Scler. 2009;10:79–84.
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Zollino M, Luigetti M, del Grande A, Lattante S, Marangi G, et al. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS. Amyotroph Lateral Scler. 2011;12:278–82.
   PubMed Web of Science ®Google Scholar
• Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:19–32.
   PubMed Web of Science ®Google Scholar
• Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology. 1988;38:405–8.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
   PubMed Web of Science ®Google Scholar
• Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571–5.
   PubMed Web of Science ®Google Scholar
• Devine MS, Kiernan MC, Heggie S, McCombe PA, Henderson RD. Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:481–7.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Pinto S, Swash M. Association of paraspinal and diaphragm denervation in ALS. Amyotroph Lateral Scler. 2010;11:63–6.
   PubMed Web of Science ®Google Scholar
• Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophysiol. 2012;123:2454–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Brooks BR, Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 2014;13:1127–38.
   PubMed Web of Science ®Google Scholar
• Balendra R, Jones A, Jivraj N, Steen IN, Young CA, Shaw PJ, et al. Use of clinical staging in amyotrophic lateral sclerosis for phase III clinical trials. J Neurol Neurosurg Psychiatry. 2015;86:45–9.
   PubMed Web of Science ®Google Scholar
• Chiò A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38–44.
   PubMed Web of Science ®Google Scholar
• Körner S, Kollewe K, Fahlbusch M, Zapf A, Dengler R, Krampfl K, et al. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve. 2011;43:636–42.
   PubMed Web of Science ®Google Scholar
• Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol. 2012;19:834–41.
   PubMed Web of Science ®Google Scholar
• Bozik ME, Mitsumoto H, Brooks BR, Rudnicki SA, Moore DH, Zhang B, et al. A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:406–13.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Simpson EP, Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2006;34:702–8.
   PubMed Web of Science ®Google Scholar
• Swash M. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2012;83:659–62.
   PubMed Web of Science ®Google Scholar
• Larrode-Pellicer P, Alberti-González O, Iñiguez-Martínez C, Santos Lasaosa S, Pérez-Lázaro C, López de Val LJ. Prognostic factors and survival in motor neuron disease. Neurologia. 2007;22:362–7.
   PubMed Web of Science ®Google Scholar
• Similowski T, Attali V, Bensimon G, Salachas F, Mehiri S, Arnulf I, et al. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J. 2000;15:332–7.
   PubMed Web of Science ®Google Scholar